Investigation on Advanced Non-Small-Cell Lung Cancer among Elderly Patients Treated with Chinese Herbal Medicine versus Chemotherapy: A Pooled Analysis of Individual Data.
Lingling SunWan Sze YimPaul Patrick FaheyShutang WangXiaoshu ZhuJing QiaoHezheng LaiLi-Zhu LinPublished in: Evidence-based complementary and alternative medicine : eCAM (2019)
There might be no significant difference in survival for elderly patients with advanced EGFR wild type NSCLC between the CHM and CT groups in the current study. And previously treated elderly patients with advanced NSCLC probably receive greater benefit from CHM. However, limited by the design and unpreplanned study hypothesis, the results must be confirmed by randomized control trial before making a conclusion.
Keyphrases
- advanced non small cell lung cancer
- small cell lung cancer
- epidermal growth factor receptor
- middle aged
- community dwelling
- computed tomography
- tyrosine kinase
- squamous cell carcinoma
- clinical trial
- magnetic resonance
- electronic health record
- double blind
- machine learning
- contrast enhanced
- phase iii
- placebo controlled
- study protocol
- brain metastases
- artificial intelligence
- big data